- Global Pharma News & Resources

Zur Rose Group successfully completed capital increase from authorised capital and sets placement price at CHF 290 per new share

Zur Rose Group AG / Key word(s): Capital Increase

09-Dec-2021 / 07:01 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.

Please find our press release about the completed capital increase under the following link:

End of ad hoc announcement
Language: English
Company: Zur Rose Group AG
Walzm├╝hlestrasse 60
8500 Frauenfeld
Phone: +41 52 724 08 14
ISIN: CH0042615283
Listed: SIX Swiss Exchange
EQS News ID: 1255736

End of Announcement EQS News Service

Editor Details

Last Updated: 09-Dec-2021